Response Genetics (RGDXQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2007 | 06-2007 | 06-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 17,860 | 19,420 | N/A |
| Receivables | 1,720 | 2,230 | N/A |
| Other current assets | 450 | 620 | 0 |
| TOTAL | $20,030 | $22,270 | $N/A |
| Non-Current Assets | |||
| Other Non-Current Assets | 10 | 20 | 0 |
| TOTAL | $10 | $20 | $N/A |
| Total Assets | $22,590 | $24,710 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 580 | 980 | 0 |
| Accrued Expenses | 770 | 2,450 | N/A |
| Other current liabilities | 3,910 | 3,750 | N/A |
| TOTAL | $5,260 | $7,190 | $N/A |
| Non-Current Liabilities | |||
| TOTAL | $1,600 | $1,620 | $N/A |
| Total Liabilities | $6,860 | $8,810 | $N/A |
| Shareholders' Equity | |||
| Common Shares | 100 | 100 | N/A |
| Retained earnings | -19,400 | -18,510 | N/A |
| Other shareholders' equity | -20 | 0 | 0 |
| TOTAL | $15,720 | $15,900 | $N/A |
| Total Liabilities And Equity | $22,580 | $24,710 | $0 |